Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are These Four Stocks Tanking Amid Today’s Rally?

Page 1 of 2

U.S stocks are trending higher today following some positive economic data. Consumer prices and manufacturing output picked up after two months of decline, providing further foundation for a possible interest rate hike in December. There are several stock that have not followed the main trend and are still in red territory at noon. Let’s have a look at what is driving Osiris Therapeutics, Inc. (NASDAQ:OSIR), Dicks Sporting Goods Inc (NYSE:DKS), Urban Outfitters, Inc. (NASDAQ:URBN) and Sunedison Inc (NYSE:SUNE) lower today.

down, business, bad, price, risk, money, arrow, vector, drop, sales, loss, stock, fall, broker, red, concept, diagram


Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 53 percentage points since the end of August 2012. These stocks returned a cumulative of 102% vs. 48.7% gain for the S&P 500 Index (read the details). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

Osiris Therapeutics, Inc. (NASDAQ:OSIR) is in hot water after Rosen Law Firm has announced an investigation on allegations of having issued misleading business information to investors. The company announced yesterday its intention to revise revenue accounting for three contracts that will lead to a decrease in revenues for 2014 fourth quarter, 2015 first and second quarter and an increase in revenues for the third quarter. Shares have plunged by as much as 30% this morning and are currently trading at $11.44 apiece.

Follow Osiris Therapeutics Inc. (NASDAQ:OSIR)
Trade (NASDAQ:OSIR) Now!

Mitchell Blutt, the manager of Consonance Capital Management, is bullish on Osiris Therapeutics, Inc. (NASDAQ:OSIR), having boosted his stake by 73% to 2.03 million shares worth $37,6 million. Julian Baker and Felix Baker have made no change to their investment in Osiris and their fund, Baker Bros. Advisors, continues to hold 499,193 shares, now worth $9.22 million.

The slump at Dicks Sporting Goods Inc (NYSE:DKS)‘s Golf Galaxy has continued in the third quarter, while sales at its namesake stores barely improved. The company’s latest round of financial results has been disappointing, missing analyst estimates. Third-quarter sales stood at $1.64 billion, below estimates of $1.67 billion, while earnings, adjusted for non-recurring costs, of $0.45 per share missed the Street’s expectations of $0.46 per share. The stock fell off a cliff this morning, tanking by as much as 18% before recovering some of the lost ground to $37.03 per share.

Follow Dicks Sporting Goods Inc (NYSE:DKS)
Trade (NYSE:DKS) Now!

Cliff Asness believes Dicks Sporting Goods Inc (NYSE:DKS) is a good buy on a dip, having upped his stake during the third quarter. His fund, AQR Capital Management, reported a 28% increase in its holding of the stock to 1.53 million shares valued at $75.8 million. Dmitry Balyasny changed his mind and started buying the stock again during the quarter, taking his position to 874,620 shares worth approximately $43.4 million.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!